Posts
Hey everyone! 👋 I hope you're all geared up for FFGS session at 4PM
Zoom Meeting Details: * Topic: CliniLaunch FFGS Edition 11 * Time: Jul 22, 2024, 4PM IST * Topic: Integrating AI in Telemedicine and Remote Monitoring * Join: https://us06web.zoom.us/j/83987913125?pwd=3BEnCc02Bpi0udg1SG1RAEZQDr0RYw.1 * Meeting ID: 839 8791 3125 * Passcode: 130967
Join the Much-Requested SAS Guest Session with Mr Sunil Gupta
Join the Much-Requested SAS Guest Session with Mr Sunil Gupta Dear Students, Monday Morning Greetings!! We are excited to invite you to the highly anticipated SAS Guest Lecture, *”Career Prospects in Clinical SAS for Freshers,”* scheduled for July 22, 2024, from 8:00 PM to 9:00 PM IST.* Please join 15 minutes early to ensure a smooth start.* *Speaker:* Sunil Gupta, Principal SAS Programmer, CDISC SME, and Founder of SASSavvy.com and R-Guru.com, with 30 years of experience. Key Associations: Experis, TalentMine, Cytel, BioMarin, Ionis Pharmaceuticals, BioBridges, Neustar MarketShare, IQVIA, Amgen, Synteract. *Zoom Meeting Details:* *Join:* https://us06web.zoom.us/j/84765289905?pwd=Sdfn5lxFQCn7rJS6XV2PNkmMqnXoot.1 *Meeting ID:* 847 6528 9905 *Passcode:* 457395 This session will provide valuable insights into the career opportunities available in the field of clinical SAS for freshers. Don't miss out on this chance to learn from one of the industry's top experts! We look forward to your participation! Regards Shweta
CliniLaunch Fast Forward Guest Series Edition 11: Dr. Hari Prasad Kovelamudi
CliniLaunch Fast Forward Guest Series Edition 11: Dr. Hari Prasad Kovelamudi Dear Students, Monday Morning Greetings!! Join us for CliniLaunch Fast Forward Guest Series Edition 11 with Dr. Hari Prasad Kovelamudi on July 22, 2024, at 04:00PM IST. Zoom Meeting Details: * Topic: CliniLaunch FFGS Edition 11 * Time: Jul 22, 2024, 08:30 AM IST * Topic: Integrating AI in Telemedicine and Remote Monitoring * Join: https://us06web.zoom.us/j/83987913125?pwd=3BEnCc02Bpi0udg1SG1RAEZQDr0RYw.1 * Meeting ID: 839 8791 3125 * Passcode: 130967 About Dr. Hari Prasad Kovelamudi Dr. Hari is the Group Chairman and non-executive director of Quality Care India Ltd., overseeing Care Group of Hospitals, KIMSHEALTH, and Evercare Hospitals. He also serves as the President of Apollo Group - Hospitals and is the Founder Chairman of the Society for Emergency Medicine India. See you all at 3:45 PM, Kindly join 15 minutes early. Regards Shweta
Fast Forward Guest Series Edition 11 Registration
Dear Students, Greetings!! We are thrilled to invite you to the Fast Forward Guest Series Edition 11, themed "Pioneering Excellence: Insights from Healthcare CEOs" from 22nd July to 26th July. This is a unique opportunity to engage with visionary leaders revolutionising the healthcare industry with innovative startups. Join us during this week-long event to gain valuable insights, be inspired by their journeys, and explore the future of healthcare innovation. Don’t miss this chance to broaden your horizons and fuel your passion for making a difference in the world of healthcare. Register now to secure your spot: https://forms.office.com/r/B9TQc4GL61 We look forward to seeing you there and embarking on this exciting journey together! Best Regards, Shweta 9958282532
Regular sessions for Tomorrow !!!!
Hello CLRIans, This is to infrom everyone that tomorrow classes willl be on the regular schedule and institute remains open as usual0. Thanks and regards
Understanding Clinical Trials: Importance, Phases, and Participant Criteria
Welcome to Clinilaunch Knowledge Pod! In this informative video, we delve deep into the world of clinical trials, exploring their significance, phases, and the essential criteria for participants. Clinical trials, also known as clinical research, play a pivotal role in advancing healthcare by studying health and illness in people. They pave the way for new medications and therapies from prevention to diagnosis and treatment. But why are clinical trials crucial? We discuss this question, drawing insights from historical incidents like the thalidomide tragedy, which underscored the importance of safety, efficacy, and toxicity testing in drug development.Watch Full Video
CliniLaunch Excellence - Success Story | Career Growth
Meet Likith, our successful student who got placed at IQVIA! In this video, Likith shares his journey with CliniLaunch, shedding light on his experiences and the invaluable support from our amazing faculty. Curious about what made his journey so special? Watch to hear his story and insights! Don’t miss out—Watch the full video on our YouTube channel.YouTube
🌟 Exciting Announcement: Join Us for an Exclusive AI & ML in Healthcare Demo Session! 🏥🤖
Hello Healthcare Innovators! Are you ready to revolutionize the future of healthcare through cutting-edge AI and Machine Learning technologies? We're thrilled to invite you to a special Demo Session where we'll explore the incredible potential of AI & ML in transforming patient care, diagnostics, and operational efficiency within healthcare systems. Link for session- 📅 Date: 13/07/2024 🕒 Time: 6:00PM Link for the class - Join Zoom Meeting https://us06web.zoom.us/j/89991848070?pwd=i1LABPgl9XhX4lFqzeRKnWmIYlvWyx.1 Meeting ID: 899 9184 8070 Passcode: 877805
Breakthrough in Brain Cancer Treatment
Bengaluru, India – A groundbreaking development in the fight against brain cancer has emerged from the Indian Institute of Technology Delhi. Researchers at IIT Delhi have reported promising results in pre-clinical trials for a novel treatment targeting glioblastoma, the most aggressive form of brain cancer. The IIT Delhi team, led by Dr. Jayanta Bhattacharyya, has developed a nanoformulation called Immunosomes, which combines a CD40 agonist antibody with a small molecule inhibitor. This innovative approach has shown remarkable efficacy in eliminating brain tumors in mice models. Importantly, the treatment not only eradicated the tumors but also stimulated a robust immune response, preventing tumor recurrence even after re-challenge. These findings, published in the prestigious journal Biomaterials, offer new hope for patients suffering from this devastating disease. CliniLaunch Research Institute closely monitors such advancements in cancer research, recognizing their potential to transform patient care. We are excited by these promising results and eagerly await further developments in the clinical pipeline. For more details, please refer to the original article: https://government.economictim...